Ajan Reginald: Biotech Entrepreneur
February 25, 2023• Latest, Most Popular, Roquefort, Start-Up, United Kingdom
Roquefort Therapeutics (LSE: ROQ, QTCQB: ROQAF) (Roquefort) is an LSE main-market-listed BioTech company exploring the high-value and...
Read More → Read More: Ajan Reginald: Biotech Entrepreneur
Roquefort Therapeutics PLC (LSE: ROQ) and Randox Laboratories Strike Exclusive License Agreement for Medical Diagnostics
February 24, 2023• Editor's Pick, Latest, Most Popular, Roquefort, Technology, Top Stories, United Kingdom
Roquefort Therapeutics PLC (LSE: ROQ, OTCQB: ROQAF), a cancer-focused biotechnology company, has made a significant announcement recently....
Read More → Read More: Roquefort Therapeutics PLC (LSE: ROQ) and Randox Laboratories Strike Exclusive License Agreement for Medical Diagnostics
Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies
January 26, 2023• Latest, Most Popular, Roquefort, SLIDER, Top Stories, United Kingdom • One Comment
Roquefort Therapeutics (LSE: ROQ, OTCQB: ROQAF) (“Roquefort” or the “Company”) announces that two of its Midkine (MDK) antibody...
Read More → Read More: Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies
Roquefort Therapeutics and CEO Ajan Reginald: An Inspiring Story
January 10, 2023• Company - Clients, Latest, Most Popular, Roquefort, Top Stories, United Kingdom
Roquefort Therapeutics PLC (LSE: ROQ) (Roquefort or the “Company”) is a public company listed on the Main Market of the London stock...
Read More → Read More: Roquefort Therapeutics and CEO Ajan Reginald: An Inspiring Story